Transfusion reactions are defined as adverse events associated with the transfusion of whole blood or one of its components. These may range in severity from minor to life-threatening. Reactions can occur during the transfusion (acute transfusion reactions) or days to weeks later (delayed transfusion reactions) and may be immunologic or non-immunologic. A reaction may be difficult to diagnose as it can present with non-specific, often overlapping symptoms. The most common signs and symptoms include fever, chills, urticaria (hives), and itching. Some symptoms resolve with little or no treatment. However, respiratory distress, high fever, hypotension (low blood pressure), and red urine (hemoglobinuria) can indicate a more serious reaction.
Types of transfusion reactions include the following: acute hemolytic, delayed hemolytic, febrile non-hemolytic, anaphylactic, simple allergic, septic (bacterial contamination), transfusion-related acute lung injury (TRALI), and transfusion-associated circulatory overload (TACO). All suspected reactions should result in immediately stopping the transfusion and notifying the blood bank and treating clinician.
Immune-mediated transfusion reactions typically occur due to mismatch or incompatibility of the transfused product and the recipient. They include naturally occurring antibodies in the blood recipient (such as anti-A, anti-B which are typically responsible for acute hemolytic transfusion reactions) as well as antibodies made in response to foreign antigens (alloantibodies). These alloantibodies account for many reactions including mild allergic, febrile non-hemolytic, acute hemolytic and anaphylactic. Antibodies present in the blood donor can also cause reactions and are thought to be involved in transfusion-associated lung injury (TRALI).
Non-immunologic reactions are usually caused by the physical effects of blood components or the transmission of disease. Bacterial contamination, for example, results in septic transfusion reactions and is caused by bacterial and/or endotoxin contamination of a blood product. This may happen at the time of collection due to inadequate blood donor arm disinfection, the presence of bacteria in the donor’s circulation at the time of collection, or due to improper product handling after collection.
Transfusion reactions can also occur unrelated to factors intrinsic to the blood. Examples of these include transfusion-associated volume overload (TACO) and hypothermia.
Transfusion reactions range in frequency from relatively common, (mild allergic and febrile non-hemolytic reactions) to rare (anaphylaxis, acute hemolytic, and sepsis). Fatal adverse events have been reported to occur most commonly with TRALI, and long-term or later adverse events are typically the result of disease transmission.
The severity and incidence vary depending on the type of transfusion reaction, the prevalence of disease in the donor population, and the extent of follow-up care the patient receives. Due to advances in donor screening, improved testing, and automated data systems, the risks and fatalities associated with the transfusion of blood products continue to decrease.
Acute Transfusion Reactions
Delayed Transfusion Reactions
A thorough understanding of the patient’s medical history and state of health is needed before the transfusion is started. Vital signs are monitored and typically recorded at 15-minute intervals. A small amount of change in vital signs during transfusion may be considered “normal.” These changes may include the following: plus or minus 0.5 C in temperature, plus or minus 5 respirations per minute, plus or minus 10 beats per minute in heart rate, and plus or minus 20 mm Hg in blood pressure. It is important to note that changes greater than these parameters do not mean that there is a transfusion reaction, it suggests that the bedside nurse should be extra vigilant in monitoring for a reaction. Abnormal responses include hives, itching, fever greater than 1 C above the temperature at the start of transfusion, chills, hypotension, and dyspnea.
Urticaria (hives) and/or itching can be the presenting sign of a mild allergic reaction, but can also be associated with the onset of a life-threatening anaphylactic reaction. The transfusion should be stopped, and the patient should be carefully monitored for progression of symptoms.
Fever and/or chills are most commonly associated with a febrile, non-hemolytic reaction, however; they can also be the first sign of a more serious acute hemolytic reaction, TRALI, or septic transfusion reaction. If the temperature rises 1 C or higher from the temperature at the start of transfusion, the transfusion should be stopped. Acute hemolytic reaction or bacterial contamination should be suspected if there is a greater rise in temperature, or more serious symptoms (e.g., rigors).
Dyspnea, or shortness of breath, is a concerning sign that can often be seen with more severe reactions including anaphylaxis, TRALI, and TACO. It can also be seen by itself without accompanying symptoms.
Hypotension can be seen with an acute hemolytic reaction, septic transfusion reactions, anaphylaxis, and TRALI. They have also been reported without the presence of any other associated transfusion reaction.
Hypothermia can be seen with large volume transfusions of refrigerated products. The only intervention needed is warming the patient and/or blood product.
When a transfusion reaction is suspected, the transfusion should be immediately stopped, and the intravenous line should be kept open using appropriate fluids (usually 0.9% saline). A clerical check should be performed by examining the product bag and confirming the patient’s identification. The patient’s vital signs should be monitored and recorded at 15-minute intervals. A post-transfusion blood sample should be drawn and sent to the lab, in addition to sending the bag and tubing if possible. The blood bank generally completes additional testing and clerical checks to rule out an incompatible transfusion.
Treatment of specific transfusion reactions is most often supportive. For example, antihistamines (such as diphenhydramine) can be given for a mild allergic reaction, or an antipyretic can be given for a non-hemolytic febrile transfusion reaction.
Transfusion reactions are influenced by many factors including the type of component being transfused, the storage requirements, and the patient’s co-morbid conditions at the time of transfusion. Understanding how to quickly identify transfusion reactions and appropriately manage and treat the patient ensures optimal patient care.
Blood transfusions are often necessary in medicine, and all healthcare workers have to be familiar with transfusion reactions. Patient on any ward can receive a blood transfusion and similarly all nurses have to know the potential complications and how to manage them. The majority of blood transfusion reactions occur because of a clerical/nursing error. While some reactions can be severe and lead to death, many transfusion reactions are benign. Anaphylactic reactions from a blood transfusion are very rare but often result in a fatality. Other reactions include TRALI which ranges from 1-9% and often requires intensive pulmonary support to prevent a fatal outcome. The incidence of bacterial contamination is rare but can occur from both gram-negative and gram-positive organisms. The key to reducing the morbidity is vigilance on the part of the nurse. During the patient medical history, one should ask about prior transfusions and any complications. If there is ever any doubt about the patient's blood group or the blood type being administered, the laboratory should be asked to reconfirm the status. (Level V)
|||Sirianni G,Perri G,Callum J,Gardner S,Berall A,Selby D, A Retrospective Chart Review of Transfusion Practices in the Palliative Care Unit Setting. The American journal of hospice [PubMed PMID: 30336680]|
|||McClosky ME,Cimino Brown D,Weinstein NM,Chappini N,Taney MT,Marryott K,Callan MB, Prevalence of naturally occurring non-AB blood type incompatibilities in cats and influence of crossmatch on transfusion outcomes. Journal of veterinary internal medicine. 2018 Oct 11 [PubMed PMID: 30307648]|
|||Land KJ,Townsend M,Goldman M,Whitaker BI,Perez GE,Wiersum-Osselton JC, International validation of harmonized definitions for complications of blood donations. Transfusion. 2018 Oct 8 [PubMed PMID: 30294786]|
|||Aubron C,Aries P,Le Niger C,Sparrow RL,Ozier Y, How clinicians can minimize transfusion-related adverse events? Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine. 2018 Nov [PubMed PMID: 30197000]|
|||Jasinski S,Glasser CL, Catastrophic Delayed Hemolytic Transfusion Reaction in a Patient With Sickle Cell Disease Without Alloantibodies: Case Report and Review of Literature. Journal of pediatric hematology/oncology. 2018 Aug 31 [PubMed PMID: 30179992]|
|||Erony SM,Marshall CE,Gehrie EA,Boyd JS,Ness PM,Tobian AAR,Carroll KC,Blagg L,Shifflett L,Bloch EM, The epidemiology of bacterial culture-positive and septic transfusion reactions at a large tertiary academic center: 2009 to 2016. Transfusion. 2018 Aug [PubMed PMID: 30153333]|
|||Py JY,Cabezon B,Sapey T,Jutant T, Unacknowledged adverse transfusion reactions: Are they a mine to dig? Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine. 2018 Feb [PubMed PMID: 28690037]|
|||Jacquot C,Delaney M, Efforts Toward Elimination of Infectious Agents in Blood Products. Journal of intensive care medicine. 2018 Oct [PubMed PMID: 29562814]|
|||Siddon AJ,Kenney BC,Hendrickson JE,Tormey CA, Delayed haemolytic and serologic transfusion reactions: pathophysiology, treatment and prevention. Current opinion in hematology. 2018 Nov [PubMed PMID: 30124474]|
|||Tariket S,Sut C,Hamzeh-Cognasse H,Laradi S,Garraud O,Cognasse F, Platelet and TRALI: From blood component to organism. Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine. 2018 Sep [PubMed PMID: 29631963]|
|||Scher CS, Trauma and transfusion in the geriatric patient. Current opinion in anaesthesiology. 2018 Apr [PubMed PMID: 29389749]|
|||Garraud O,Cognasse F,Laradi S,Hamzeh-Cognasse H,Peyrard T,Tissot JD,Fontana S, How to mitigate the risk of inducing transfusion-associated adverse reactions. Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine. 2018 Nov [PubMed PMID: 30139570]|
|||Fasano RM,Meyer EK,Branscomb J,White MS,Gibson RW,Eckman JR, Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review. Transfusion medicine reviews. 2018 Jul 26 [PubMed PMID: 30122266]|
|||Strasser E, [The new hemotherapy guideline]. Der Unfallchirurg. 2018 May [PubMed PMID: 29654513]|
|||Long B,Koyfman A, Emergency Medicine Evaluation and Management of Anemia. Emergency medicine clinics of North America. 2018 Aug [PubMed PMID: 30037447]|
|||Carman M,Uhlenbrock JS,McClintock SM, CE: A Review of Current Practice in Transfusion Therapy. The American journal of nursing. 2018 May [PubMed PMID: 29664740]|
|||DeLisle J, Is This a Blood Transfusion Reaction? Don't Hesitate; Check It Out. Journal of infusion nursing : the official publication of the Infusion Nurses Society. 2018 Jan/Feb [PubMed PMID: 29293197]|